Related Experiment Video

Updated: Jun 12, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Biomedical research funding. Battle of the titans

Colin Macilwain

    Science (New York, N.Y.)
    |May 22, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
    12:38

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

    Published on: July 19, 2007

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
    13:36

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

    Published on: January 21, 2010

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
    16:26

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

    Published on: August 20, 2007

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
    12:38

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

    Published on: July 19, 2007

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
    13:36

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

    Published on: January 21, 2010

    Related Concept Videos

    Bioequivalence studies: Biowaivers01:13

    Bioequivalence studies: Biowaivers

    In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

    Articles linked to this work by shared authors, journal, and citation graph.

    Biology boom goes bust.

    Cell·2013

    In situ structure of the human ciliary transition zone links linker defects to primary ciliary dyskinesia.

    Science (New York, N.Y.)·2026

    Glycan recognition by a plant damage-sensing immune receptor.

    Science (New York, N.Y.)·2026

    Noncoding transcription controls the developmental dynamics of long-range gene regulation.

    Science (New York, N.Y.)·2026

    Catching a glimpse of complex relaxation.

    Science (New York, N.Y.)·2026

    Platinum chemotherapy ages the liver.

    Science (New York, N.Y.)·2026

    Decondensing cancer immunotherapy.

    Science (New York, N.Y.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us